ArticleThe oncologist2025

Immune-related adverse events, survival outcomes, and next steps in patients with stage III melanoma: real-world experience at a National Cancer Institute-designated Comprehensive Cancer Center.

Kevin G Zablonski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.